Annual SGA
$31.05 M
+$6.23 M+25.12%
December 31, 2023
Summary
- As of February 26, 2025, MIST annual SGA is $31.05 million, with the most recent change of +$6.23 million (+25.12%) on December 31, 2023.
- During the last 3 years, MIST annual SGA has risen by +$14.82 million (+91.38%).
- MIST annual SGA is now at all-time high.
Performance
MIST SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$5.65 M
-$1.19 M-17.44%
September 30, 2024
Summary
- As of February 26, 2025, MIST quarterly SGA is $5.65 million, with the most recent change of -$1.19 million (-17.44%) on September 30, 2024.
- Over the past year, MIST quarterly SGA has dropped by -$2.99 million (-34.56%).
- MIST quarterly SGA is now -34.56% below its all-time high of $8.64 million, reached on September 30, 2023.
Performance
MIST Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.36 B
-$42.77 M-3.24%
September 30, 2024
Summary
- As of February 26, 2025, MIST TTM SGA is -$1.36 billion, with the most recent change of -$42.77 million (-3.24%) on September 30, 2024.
- Over the past year, MIST TTM SGA has dropped by -$1.39 billion (-4740.49%).
- MIST TTM SGA is now -2239.68% below its all-time high of -$58.27 million.
Performance
MIST TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MIST Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.1% | -34.6% | -4740.5% |
| 3 y3 years | +91.4% | -9.5% | -5388.5% |
| 5 y5 years | +345.2% | -9.5% | -5388.5% |
MIST Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.0% | -34.6% | +7.1% | -82.1% | at low |
| 5 y | 5-year | at high | +95.3% | -34.6% | +88.7% | -278.9% | at low |
| alltime | all time | at high | +1079.6% | -34.6% | +402.5% | -2239.7% | at low |
Milestone Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.65 M(-17.4%) | $27.68 M(-9.7%) |
| Jun 2024 | - | $6.85 M(+0.1%) | $30.67 M(-3.1%) |
| Mar 2024 | - | $6.84 M(-18.1%) | $31.64 M(+1.9%) |
| Dec 2023 | $31.05 M(+25.1%) | $8.35 M(-3.4%) | $31.05 M(+5.7%) |
| Sep 2023 | - | $8.64 M(+10.6%) | $29.38 M(+7.1%) |
| Jun 2023 | - | $7.81 M(+25.1%) | $27.44 M(+6.5%) |
| Mar 2023 | - | $6.25 M(-6.5%) | $25.78 M(+3.9%) |
| Dec 2022 | $24.81 M(+27.9%) | $6.68 M(-0.3%) | $24.81 M(+2.8%) |
| Sep 2022 | - | $6.70 M(+9.0%) | $24.13 M(+9.8%) |
| Jun 2022 | - | $6.15 M(+16.5%) | $21.97 M(+6.2%) |
| Mar 2022 | - | $5.28 M(-12.0%) | $20.68 M(+6.6%) |
| Dec 2021 | $19.40 M | $6.00 M(+32.2%) | $19.40 M(+18.3%) |
| Sep 2021 | - | $4.54 M(-6.6%) | $16.40 M(+4.3%) |
| Jun 2021 | - | $4.86 M(+21.6%) | $15.71 M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $4.00 M(+33.5%) | $15.34 M(-5.5%) |
| Dec 2020 | $16.22 M(+2.1%) | $3.00 M(-22.3%) | $16.22 M(-9.7%) |
| Sep 2020 | - | $3.86 M(-14.0%) | $17.97 M(-1.8%) |
| Jun 2020 | - | $4.48 M(-8.2%) | $18.29 M(+3.8%) |
| Mar 2020 | - | $4.89 M(+3.0%) | $17.62 M(+10.8%) |
| Dec 2019 | $15.90 M(+128.0%) | $4.74 M(+13.5%) | $15.89 M(+13.8%) |
| Sep 2019 | - | $4.18 M(+9.8%) | $13.96 M(+19.8%) |
| Jun 2019 | - | $3.81 M(+20.3%) | $11.66 M(+29.9%) |
| Mar 2019 | - | $3.17 M(+12.6%) | $8.97 M(+28.7%) |
| Dec 2018 | $6.97 M(+164.9%) | $2.81 M(+49.9%) | $6.97 M(+67.5%) |
| Sep 2018 | - | $1.87 M(+66.6%) | $4.16 M(+81.9%) |
| Jun 2018 | - | $1.13 M(-3.4%) | $2.29 M(+96.6%) |
| Mar 2018 | - | $1.16 M | $1.16 M |
| Dec 2017 | $2.63 M | - | - |
FAQ
- What is Milestone Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual SGA year-on-year change?
- What is Milestone Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly SGA year-on-year change?
- What is Milestone Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals TTM SGA year-on-year change?
What is Milestone Pharmaceuticals annual SGA?
The current annual SGA of MIST is $31.05 M
What is the all time high annual SGA for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual SGA is $31.05 M
What is Milestone Pharmaceuticals annual SGA year-on-year change?
Over the past year, MIST annual SGA has changed by +$6.23 M (+25.12%)
What is Milestone Pharmaceuticals quarterly SGA?
The current quarterly SGA of MIST is $5.65 M
What is the all time high quarterly SGA for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly SGA is $8.64 M
What is Milestone Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, MIST quarterly SGA has changed by -$2.99 M (-34.56%)
What is Milestone Pharmaceuticals TTM SGA?
The current TTM SGA of MIST is -$1.36 B
What is the all time high TTM SGA for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high TTM SGA is -$58.27 M
What is Milestone Pharmaceuticals TTM SGA year-on-year change?
Over the past year, MIST TTM SGA has changed by -$1.39 B (-4740.49%)